{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:57:53Z","timestamp":1781323073189,"version":"3.54.1"},"reference-count":37,"publisher":"Pharmaceutical Society of Japan","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,6,10]]},"DOI":"10.1248\/bpb.b26-00170","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:11:15Z","timestamp":1781043075000},"page":"946-956","source":"Crossref","is-referenced-by-count":0,"title":["Partial Reelin Deficiency Modulates Behavioral and Prefrontal Effects of Mild Prenatal Poly(I:C) Exposure"],"prefix":"10.1248","volume":"49","author":[{"given":"Keiko","family":"Iwata","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, School of Pharmaceutical Sciences, Wakayama Medical University, 25\u20131 Shichibancho, Wakayama 640\u20138156, Japan"},{"name":"Research Center for Child Mental Development, University of Fukui, Fukui 910\u20131193, Japan"},{"name":"Department of Development of Functional Brain Activities, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Fukui 910\u20131193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Shintani","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, School of Pharmaceutical Sciences, Wakayama Medical University, 25\u20131 Shichibancho, Wakayama 640\u20138156, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Research Center for Child Mental Development, University of Fukui, Fukui 910\u20131193, Japan"},{"name":"Department of Development of Functional Brain Activities, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Fukui 910\u20131193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Owen MJ, O\u2019Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. <i>Br. J. Psychiatry<\/i>, <b>198<\/b>, 173\u2013175 (2011).","DOI":"10.1192\/bjp.bp.110.084384"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lai MC, Lombardo MV, Baron-Cohen S. Autism. <i>Lancet<\/i>, <b>383<\/b>, 896\u2013910 (2014).","DOI":"10.1016\/S0140-6736(13)61539-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Geschwind DH, State MW. Gene hunting in autism spectrum disorder: on the path to precision medicine. <i>Lancet Neurol.<\/i>, <b>14<\/b>, 1109\u20131120 (2015).","DOI":"10.1016\/S1474-4422(15)00044-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. <i>J. Neurosci.<\/i>, <b>26<\/b>, 4752\u20134762 (2006).","DOI":"10.1523\/JNEUROSCI.0099-06.2006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. <i>Science<\/i>, <b>353<\/b>, 772\u2013777 (2016).","DOI":"10.1126\/science.aag3194"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. <i>Nature<\/i>, <b>413<\/b>, 732\u2013738 (2001).","DOI":"10.1038\/35099560"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Haddad FL, Patel SV, Schmid S. Maternal immune activation by poly I: C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia. <i>Neurosci. Biobehav. Rev.<\/i>, <b>113<\/b>, 546\u2013567 (2020).","DOI":"10.1016\/j.neubiorev.2020.04.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Geschwind DH, Flint J. Genetics and genomics of psychiatric disease. <i>Science<\/i>, <b>349<\/b>, 1489\u20131494 (2015).","DOI":"10.1126\/science.aaa8954"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) D\u2019Arcangelo G, Miao GG, Chen SC, Scares HD, Morgan JI, Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. <i>Nature<\/i>, <b>374<\/b>, 719\u2013723 (1995).","DOI":"10.1038\/374719a0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rice DS, Curran T. Role of the reelin signaling pathway in central nervous system development. <i>Annu. Rev. Neurosci.<\/i>, <b>24<\/b>, 1005\u20131039 (2001).","DOI":"10.1146\/annurev.neuro.24.1.1005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Pujadas L, Gruart A, Bosch C, Delgado L, Teixeira CM, Rossi D, de Lecea L, Martinez A, Delgado-Garcia JM, Soriano E. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. <i>J. Neurosci.<\/i>, <b>30<\/b>, 4636\u20134649 (2010).","DOI":"10.1523\/JNEUROSCI.5284-09.2010"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Folsom TD, Fatemi SH. The involvement of Reelin in neurodevelopmental disorders. <i>Neuropharmacology<\/i>, <b>68<\/b>, 122\u2013135 (2013).","DOI":"10.1016\/j.neuropharm.2012.08.015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>95<\/b>, 15718\u201315723 (1998).","DOI":"10.1073\/pnas.95.26.15718"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce DA. Reelin signaling is impaired in autism. <i>Biol. Psychiatry<\/i>, <b>57<\/b>, 777\u2013787 (2005).","DOI":"10.1016\/j.biopsych.2004.12.018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation\/inhibition in key neural systems. <i>Genes Brain Behav.<\/i>, <b>2<\/b>, 255\u2013267 (2003).","DOI":"10.1034\/j.1601-183X.2003.00037.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. <i>Trends Neurosci.<\/i>, <b>35<\/b>, 57\u201367 (2012).","DOI":"10.1016\/j.tins.2011.10.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Cellot G, Cherubini E. GABAergic signaling as therapeutic target for autism spectrum disorders. <i>Front Pediatr.<\/i>, <b>2<\/b>, 70 (2014).","DOI":"10.3389\/fped.2014.00070"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA<sub>A<\/sub> receptor downregulation in brains of subjects with autism. <i>J. Autism Dev. Disord.<\/i>, <b>39<\/b>, 223\u2013230 (2009).","DOI":"10.1007\/s10803-008-0646-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Oblak AL, Gibbs TT, Blatt GJ. Reduced GABA<sub>A<\/sub> receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. <i>Brain Res.<\/i>, <b>1380<\/b>, 218\u2013228 (2011).","DOI":"10.1016\/j.brainres.2010.09.021"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kang HJ, Kawasawa YI, Cheng F, <i>et al<\/i>. Spatio-temporal transcriptome of the human brain. <i>Nature<\/i>, <b>478<\/b>, 483\u2013489 (2011).","DOI":"10.1038\/nature10523"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Robertson CE, Ratai EM, Kanwisher N. Reduced GABAergic action in the autistic brain. <i>Curr. Biol.<\/i>, <b>26<\/b>, 80\u201385 (2016).","DOI":"10.1016\/j.cub.2015.11.019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA, Pletnikov MV. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. <i>Biol. Psychiatry<\/i>, <b>68<\/b>, 1172\u20131181 (2010).","DOI":"10.1016\/j.biopsych.2010.09.022"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Vuillermot S, Joodmardi E, Perlmann T, \u00d6gren SO, Feldon J, Meyer U. Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. <i>J. Neurosci.<\/i>, <b>32<\/b>, 436\u2013451 (2012).","DOI":"10.1523\/JNEUROSCI.4831-11.2012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Podhorna J, Didriksen M. The heterozygous reeler mouse: behavioural phenotype. <i>Behav. Brain Res.<\/i>, <b>153<\/b>, 43\u201354 (2004).","DOI":"10.1016\/j.bbr.2003.10.033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Iwata K. Characterization of an animal model of autism and social interaction. <i>Methods Mol. Biol.<\/i>, <b>1916<\/b>, 149\u2013155 (2019).","DOI":"10.1007\/978-1-4939-8994-2_14"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. <i>Psychopharmacology<\/i>, <b>204<\/b>, 361\u2013373 (2009).","DOI":"10.1007\/s00213-009-1466-y"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Walsh RN, Cummins RA. The open-field test: a critical review. <i>Psychol. Bull.<\/i>, <b>83<\/b>, 482\u2013504 (1976).","DOI":"10.1037\/0033-2909.83.3.482"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hideshima KS, Hojati A, Saunders JM, On DM, de la Fuente Revenga M, Shin JM, Sanchez-Gonzalez A, Dunn CM, Pais AB, Pais AC, Miles MF, Wolstenholme JT, Gonzalez-Maeso J. Role of mGlu2 in the 5-HT(2A) receptor-dependent antipsychotic activity of clozapine in mice. <i>Psychopharmacology<\/i>, <b>235<\/b>, 3149\u20133165 (2018).","DOI":"10.1007\/s00213-018-5015-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O\u2019Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, Deisseroth K. Neocortical excitation\/inhibition balance in information processing and social dysfunction. <i>Nature<\/i>, <b>477<\/b>, 171\u2013178 (2011).","DOI":"10.1038\/nature10360"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Deacon RM. Digging and marble burying in mice: simple methods for <i>in vivo<\/i> identification of biological impacts. <i>Nat. Protoc.<\/i>, <b>1<\/b>, 122\u2013124 (2006).","DOI":"10.1038\/nprot.2006.20"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Angoa-P\u00e9rez M, Kane MJ, Briggs DI, Francescutti DM, Kuhn DM. Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. <i>Jove-J Vis Exp<\/i>, (2013).","DOI":"10.3791\/50978-v"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Chevallier C, Kohls G, Troiani V, Brodkin ES, Schultz RT. The social motivation theory of autism. <i>Trends Cogn. Sci.<\/i>, <b>16<\/b>, 231\u2013239 (2012).","DOI":"10.1016\/j.tics.2012.02.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Green MF, Leitman DI. Social cognition in schizophrenia. <i>Schizophr. Bull.<\/i>, <b>34<\/b>, 670\u2013672 (2008).","DOI":"10.1093\/schbul\/sbn045"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Pocklington AJ, Rees E, Walters JT, Han J, Kavanagh DH, Chambert KD, Holmans P, Moran JL, McCarroll SA, Kirov G, O\u2019Donovan MC, Owen MJ. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. <i>Neuron<\/i>, <b>86<\/b>, 1203\u20131214 (2015).","DOI":"10.1016\/j.neuron.2015.04.022"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. <i>Annu. Rev. Neurosci.<\/i>, <b>24<\/b>, 167\u2013202 (2001).","DOI":"10.1146\/annurev.neuro.24.1.167"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Rudolph U, Mohler H. GABA<sub>A<\/sub> receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. <i>Annu. Rev. Pharmacol. Toxicol.<\/i>, <b>54<\/b>, 483\u2013507 (2014).","DOI":"10.1146\/annurev-pharmtox-011613-135947"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Goeden N, Velasquez J, Arnold KA, Chan Y, Lund BT, Anderson GM, Bonnin A. Maternal inflammation disrupts fetal neurodevelopment <i>via<\/i> increased placental output of serotonin to the fetal brain. <i>J. Neurosci.<\/i>, <b>36<\/b>, 6041\u20136049 (2016).","DOI":"10.1523\/JNEUROSCI.2534-15.2016"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/6\/49_b26-00170\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:46:59Z","timestamp":1781322419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/6\/49_b26-00170\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00170","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"b26-00170"}}